Join us for an enlightening seminar featuring Dr. Gloria González Aseguinolaza on November 21, 2024, from 5:00 PM to 6:00 PM at the Luria Auditorium, Koch Institute, 500 Main Street, Cambridge, MA. This session will delve into pioneering approaches in gene therapy for treating inherited diseases. 

Dr. González Aseguinolaza, with her extensive background in both academia and industry, including her roles as Director of Innovation and Transfer at the Navarra Institute for Health Research (IdisNA) and Scientific Director at Vivet Therapeutics, will share her insights. Her groundbreaking work in gene therapy specifically targeting liver diseases and her leadership in key gene therapy societies across Spain and Europe uniquely qualify her to lead this discussion on state-of-the-art genetic interventions.

Title: “Targeting the second largest organ in the human body to fix inherited diseases”

Location: Luria Auditorium, Koch Institute, 500 Main Street, Cambridge, MA

Date: November 21, 2024, from 5:00 PM to 6:00 PM

Agenda:

• 5:00 PM - 5:45 PM: Seminar Presentation
• 5:45 PM - 6:00 PM: Q&A Session with Dr. González Aseguinolaza
• 6:30 PM - 7:30 PM: Dinner with Dr. González Aseguinolaza (limited to 25 attendees)

Following the seminar, we invite you to an exclusive dinner with Dr. González Aseguinolaza. This dinner is an excellent opportunity to further engage with her in a more intimate setting. Please note that the dinner is limited to 25 attendees on a first-come, first-served basis.

RSVP: https://docs.google.com/forms/d/e/1FAIpQLScDHTEpX97P-m2i4sS9uwdj6GiTrMjV78gsCq6hY22pEMIADg/viewform